SilTech: A New Approach to Treat Aerobic Vaginitis ()
ABSTRACT
Background: The aerobic
vaginitis (AV) is characterized by increased levels of aerobic bacteria,
vaginal inflammation and depressed levels of lactobacilli. Objective: The
purpose of this study was to investigate the therapeutic efficacy of SilTechTM vaginal softgel capsules, containing
new microcrystals of silver monovalent ions, for aerobic vaginitis (AV).
Methods: This prospective study enrolled 32 women diagnosed with AV. All
recruited women were treated with SilTechTM vaginal softgel capsules once daily
for 7 days (one course). Therapeutic efficacy was evaluated based on clinical
and microscopic criteria, and cure rates were calculated. Women who were
improved (but not cured) received a second course of therapy. Patients
classified with clinical and microscopic failure were treated using other
strategies. Results: After one course of therapy, 59.2% (19/32) of women were
cured, 19.0% (6/32) were improved (but not cured) and 21.8% (7/32) failed to
respond to the therapy. After two courses of therapy, clinical improvement was
achieved in additional two women. The therapy was very well tolerated, and
during the entire study no drop out related to the SylTechTM vaginal capsules treatment was
observed; only two patients (6.2%) experienced a mild transient burning after
application. Conclusion: SylTechTM vaginal
capsules is an effective therapeutic option for patients with AV, and most
women with AV were cured with one course of therapy.
Share and Cite:
Murina, F. , Vicariotto, F. and Di Francesco, S. (2016) SilTech: A New Approach to Treat Aerobic Vaginitis.
Advances in Infectious Diseases,
6, 102-106. doi:
10.4236/aid.2016.63013.